Business
Europe investigating rare nerve disorder after AstraZeneca shot – 7NEWS.com.au
Reports have been lodged of a rare nerve-degenerating disorder in people who have received the AstraZeneca vaccine.
Europes medicines regulator says it is reviewing reports of a rare nerve-degenerating disorder in people who have received AstraZenecas COVID-19 vaccine and has requested more detailed data on the cases from the company.
As part of a regular review of safety reports for the vaccine, Vaxzevria, the European Medicines Agencys safety committee is analysing data provided on cases of Guillain-Barre syndrome, the regulator said.
The EMA is also looking into reports of heart inflammation with Pfizer-BioNTechs…
-
General24 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Noosa News22 hours agoCCTV footage shows stolen ute slamming into fuel bowsers at Kojonup petrol station
-
Business22 hours agoWill GQG Partners shares rise from here? Macquarie reveals its forecast post-results
-
Noosa News18 hours agoThe only person detained at Brisbane’s Palestine rally